Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GENpoll: Nov 07, 2011

Drug Approval Process

Should the FDA take into account input from patients and consumers during its review of drug marketing applications?

Yes
 
  61.3%
No
 
  35.5%
Undecided
 
  3.2%

Suggest a Poll
« More Polls » « View Results »

FDA’s proposed fifth authorization of the Prescription Drug User Fee Act (PDUFA V) largely drew support from drug developers and patient groups during the agency’s meeting held October 24 and in written comments sent in through October 31. All are eager to see Congress approve it early next year, even as they differ over how to evaluate the benefits and risks of new drugs. You can read about comments sent to the FDA here. The agency plans to finalize PDUFA V and forward it to Congress by January 15, 2012. While consumer and patient groups were unhappy about being left out of the process of drafting PDUFA V, they applauded the proposal for committing to incorporate patient perspectives in reviewing new drugs. Do you think such a move is warranted? 

Related content

GEN News Highlights

MORE RELATED GEN NEWS HIGHLIGHTS

Insight & Intelligence™

MORE RELATED INSIGHT & INTELLIGENCE™

GEN Articles

MORE RELATED GEN ARTICLES

BLOG biotech

MORE RELATED BLOG BIOTECH

GEN Podcasts

MORE RELATED GEN PODCASTS

New Products

MORE RELATED NEW PRODUCTS

Best of the Web

MORE RELATED BEST OF THE WEB

GEN Polls

MORE RELATED GEN POLLS

Subscription center

BACK TO TOP

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
 

All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

GEN webinars

« View All Webinars »

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll
« More »     « View Results »     « Poll Archive »